Showing results (3001-3010 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|February 29, 2020
Economic Evaluation of Treatments for Migraine: An Assessment of the Generalizability Following a Systematic ReviewMatteo Ruggeri, Carlo Drago, Francesco Rosiello, et al.Pharmacoeconomics|March 12, 2020
A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid SyndromeKelly Fust, Michael Maschio, Michele Kohli, et al.Pharmacoeconomics|January 15, 2019
Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic ReviewNatalia Ruiz-Negrón, Jyothi Menon, Jordan B King, et al.Pharmacoeconomics|January 14, 2020
After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?Mark Sculpher, Stephen PalmerPharmacoeconomics|December 6, 2018
Q-TWiST Analysis to Assess Benefit-Risk of Pembrolizumab in Patients with PD-L1-Positive Advanced or Metastatic Non-small Cell Lung CancerMin Huang, M Catherine Pietanza, Ayman Samkari, et al.Pharmacoeconomics|November 28, 2018
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United StatesHolly Guy, Lydia Walder, Mark FisherPharmacoeconomics|January 7, 2020
Determinants of Orphan Drug Prices in GermanyFranziska Worm, Charalabos-Markos DintsiosPharmacoeconomics|March 5, 2020
Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling ApproachLih-Wen Mau, Jaime M Preussler, Linda J Burns, et al.Pharmacoeconomics|March 8, 2020
A Systematic Review of Economic Models Across the Entire Schizophrenia PathwayHuajie Jin, Paul Tappenden, Stewart Robinson, et al.Pharmacoeconomics|February 15, 2019
The Curve of Optimal Sample Size (COSS): A Graphical Representation of the Optimal Sample Size from a Value of Information AnalysisEric Jutkowitz, Fernando Alarid-Escudero, Karen M Kuntz, et al.Pageof 336